Why targeted immuno-oncology drugs sometimes fail

Researchers report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.

From http://besthealthnews.com/2019/10/why-targeted-immuno-oncology-drugs-sometimes-fail/?utm_source=rss&utm_medium=rss&utm_campaign=why-targeted-immuno-oncology-drugs-sometimes-fail

from
https://healthnews010.wordpress.com/2019/10/24/why-targeted-immuno-oncology-drugs-sometimes-fail/

From https://jamesjohnson10.blogspot.com/2019/10/why-targeted-immuno-oncology-drugs.html

from
https://jamesjohnson10.wordpress.com/2019/10/24/why-targeted-immuno-oncology-drugs-sometimes-fail/

From https://judywright2.blogspot.com/2019/10/why-targeted-immuno-oncology-drugs.html

from
https://judywright2.wordpress.com/2019/10/24/why-targeted-immuno-oncology-drugs-sometimes-fail/